Cours Delta 9 Cannabis Inc Toronto S.E.
Actions
CA2477541049
Produits pharmaceutiques
CA 2022 | 63,23 M 46,19 M 41,49 M | CA 2023 | 71,07 M 51,91 M 46,63 M | Capitalisation | 5,3 M 3,87 M 3,48 M |
---|---|---|---|---|---|
Résultat net 2022 | -27 M -19,72 M -17,72 M | Résultat net 2023 | -17 M -12,42 M -11,15 M | VE / CA 2022 | 1,13 x |
Dette nette 2022 | 62,67 M 45,78 M 41,12 M | Dette nette 2023 | 62,5 M 45,66 M 41,01 M | VE / CA 2023 | 0,95 x |
PER 2022 |
-0,27
x | PER 2023 |
-0,25
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 84,18% |
Dernier transcript sur Delta 9 Cannabis Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01/01/12 |
James Lawson
DFI | Director of Finance/CFO | 73 | - |
Todd Schubert
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Hugh Aird
BRD | Director/Board Member | 70 | 07/09/18 |
Nitin Kaushal
CHM | Chairman | 58 | 31/10/17 |
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01/01/12 |
Varia. 1 janv. | Capi. | |
---|---|---|
+55,32% | 815 Md | |
-6,75% | 352 Md | |
+13,56% | 314 Md | |
+10,68% | 303 Md | |
+16,57% | 242 Md | |
+2,04% | 224 Md | |
+13,31% | 218 Md | |
+8,48% | 168 Md | |
-2,81% | 159 Md |